Skip to main content
Clinical Trials/NCT07072533
NCT07072533Not yet recruitingNot Applicable

Effect of Blood Flow Restriction With Aerobic Training on Chest Muscles in Diaplegic Cerebral Palsy

Cairo University0 sites40 target enrollmentStarted: August 1, 2025Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Not yet recruiting
Enrollment
40
Primary Endpoint
Chest muscle strength

Study Overview

Brief Summary

To evaluate the effect of blood flow restriction combined with aerobic training on chest muscle strength in individual with diaplegic cerebral palsy

Detailed Description

combining blood flow restriction with aerobic training may enhance muscle function and endurance by increasing localized metabolic stress and systemic cardiovascular effects inducing muscular hypertrophy and strength gaining with low load training especially chest muscles which affected in individuals with diaplegic cerebral palsy.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Single (Participant)

Eligibility Criteria

Ages
12 Years to 25 Years (Child, Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •diaplegic cerebral palsy. GMFCS level I-III. medically stable.

Exclusion Criteria

  • •severe cognitive impairment. cardio respiratory contraindication. previous thoracic surgery or musculoskeletal deformities affecting chest.

Arms & Interventions

blood flow restriction combined with aerobic training

Experimental

individual will do blood flow restriction aerobic training

Intervention: blood flow restriction training (Other)

aerobic training only

Active Comparator

individual will do aerobic training

Intervention: blood flow restriction training (Other)

Outcomes

Primary Outcomes

Chest muscle strength

Time Frame: 3 months

chest muscle strength will be measured by handheld dynamometry measured in Newton

Secondary Outcomes

  • pulmonary function tests(3 months)
  • sub-maximal aerobic capacity(3 months)
  • quality f life(3 months)
  • oxygen saturation and heart rate response(3 months)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Salah Eid Ahmed Ali

Assistant Lecturer

Cairo University

Similar Trials